Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. (DRTS) Revenue
Annual & quarterly revenue history · segment & region breakdown
DRTS · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsAlpha Tau Medical Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | — |
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Alpha Tau Medical Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Alpha Tau Medical Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Alpha Tau Medical Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DRTS revenue · 4 questionsDRTS's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Alpha Tau Medical Ltd. SEC filings · GAAP · Alpha Tau Medical Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026